| Clinical Setting |
Primary |
Alternative |
| Pneumonia |
|
|
| Outpatient: |
Macrolide(µ) or Levofloxacin |
Cefuroxime |
| Hospitalized |
Levofloxacin |
Ceftriaxone + Macrolide |
Hospitalized, ICU
•No increased risk of Pseudomonas |
Ceftriaxone +
Azithromycin or Levofloxacin |
|
•With increased risk of Pseudomonas
|
Ceftazidime or Piperacillin/Tazo +Amikacin +Azithromycin or Levofloxacin
|
Ceftazidime or Piperacillin/Tazobactam +Ciprofloxacin
|
|
| Clinical Setting |
Primary |
Alternative |
| Bronchitis Acute |
|
|
| •No underlying diseases |
Antibiotics unnecessary (ƒ) |
|
| •COPD |
Trimeth-sulfa (PO) or Amoxicillin (PO)
or Doxycycline (PO) |
|
|
| Clinical Setting |
Primary |
Alternative |
| Urinary Tract Infection |
|
|
| Cystitis, pyelonephritis |
|
|
| •Outpatient |
Trimeth-sulfa (PO) |
Levofloxacin (PO) |
| •Complicated/inpatient |
Levofloxacin (PO) |
Imipenem |
| Pregnancy |
|
|
| •Cystitis, UTI |
Nitrofurantoin (PO) or Amoxicillin (PO) |
|
| •Pyelonephritis |
Cefotaxime |
|
Back to top |
| Clinical Setting |
Primary |
Alternative |
| Pelvic Inflammatory Infection |
|
|
| •Outpatient |
Levofloxacin + Metronidazole (PO) |
|
| •Inpatient |
Ceftriaxone + Doxycycline |
Clindamycin + Gentamicin + Doxycycline |
Back to top |
| Clinical Setting |
Primary |
Alternative |
| Sepsis/Bacteremia |
|
|
| •IV catheter source/shunt |
Vancomycin + Ceftazidime |
Vancomycin + Imipenem |
| •Unknown source |
Imipenem ±Vancomycin ± Amikacin |
Ceftazidime ±Vancomycin ± Amikacin |
Back to top |
| Clinical Setting |
Primary |
Alternative |
| Skin and Soft Tissue |
|
|
| Cellulitis/Post surgical |
Cefazolin |
Ampicillin/Sulbactam |
| Necrotizing/Complicated* |
Imipenem + Amikacin |
Timentin |
| Diabetic Foot |
|
|
| •Moderate |
Amoxicillin/clavulanate (PO) or Ampicillin/sulbactam (IV) |
Levofloxacin + Metronidazole (PO) or
Levofloxacin + Clindamycin |
| •Limb/life-threatening |
Imipenem
SURGICAL CONSULT |
|
Back to top |
| Clinical Setting |
Primary |
Alternative |
| Intra-Abdominal Infection |
|
|
| Stable |
Amoxicillin/clavulanate (PO) or Ampicillin/sulbactam (IV) |
Levofloxacin + Metronidazole (PO)
|
| Critical infection* |
Piperacillin/Tazo + Tobramycin |
Imipenem/cilastatin |
Back to top |
| Clinical Setting |
Primary |
Alternative |
| C. Difficile Colitis |
|
|
| C. Difficile Colitis |
Metronidazole (PO) |
|
|
| Clinical Setting |
Primary |
Alternative |
| Acute Bacterial Menngitis* |
|
|
| Competent host |
Ceftriaxone + Vancomycin |
Chloramphenicol + Vancomycin |
| Post-op or post trauma |
Ceftazidime + Vancomycin |
CONSIDER ID CONSULT |
| Immunocompromised |
Ceftazidime + Ampicillin + Vancomycin |
|
Back to top |
| Clinical Setting |
Primary |
Alternative |
| Candidiasis |
|
|
| Line-related infection |
Remove line |
Remove line + Fluconazole |
| Candidemia, or suspected candidiasis |
Fluconazole (†) |
Amphotericin B |
|
|
Legend
* Consider ID consult
# Single blood isolates of Gram Positive Cocci -- consider as possible contaminant
PO Oral forms active/preferred
ƒ Treat symptomatically (analgesic, cough suppressant, etc.)
µ Macrolides - azithromycin, clarithromycin, erythromycin
† Fluconazole should be given PO whenever GI tract absorption permits
Back to top |